JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 30.02.
Share Price | ₹279.9 | Mar 28,2024 |
Market Cap | ₹736.0 Cr | |
Earnings-TTM | ₹24.5 Cr | TTM-Standalone Results |
Price/Earnings | 30.02x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹736.0 Cr] as on Mar 28,2024
(/) Earnings [ ₹24.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 30.02x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 30.02 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 19.91x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 12.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 5.81x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
JAGSONPAL PHARMACEUTICALS | 24.52 | 30.02 | 736.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 43.21 | 388,812.0 |
CIPLA LTD | 3,744.03 | 32.23 | 120,673.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.71 | 102,679.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 34.24 | 101,152.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 65.97 | 91,234.9 |
MANKIND PHARMA LTD | 1,743.30 | 52.79 | 92,029.2 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 58.93 | 88,034.7 |
LUPIN LTD | 1,809.74 | 40.74 | 73,722.0 |
AUROBINDO PHARMA LTD | 2,777.89 | 22.98 | 63,835.1 |
ABBOTT INDIA LTD | 1,145.58 | 49.98 | 57,258.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.71x |
Max industry PE | 65.97x |
Median industry PE | 40.74x |
Average industry PE | 40.98x |
You may also like the below Video Courses